BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37840157)

  • 1. Medium-term antifungal effects of methylene blue versus flavin mononucleotide in the treatment of moderate toenail onychomycosis.
    Gómez C; Schuele G; Alberdi E
    Mycoses; 2024 Jan; 67(1):e13661. PubMed ID: 37840157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urea versus fractional Er:YAG laser pretreatment of methylene blue photodynamic therapy in the treatment of moderate toenail onychomycosis: short- and medium-term effects.
    Alberdi E; Gómez C
    Arch Dermatol Res; 2023 May; 315(4):787-794. PubMed ID: 36316511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylene blue vs methyl aminolevulinate photodynamic therapy in combination with oral terbinafine in the treatment of severe dermatophytic toenail onychomycosis: Short- and long-term effects.
    Alberdi E; Gómez C
    Mycoses; 2020 Aug; 63(8):859-868. PubMed ID: 32506733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue-mediated photodynamic therapy may be superior to 5% amorolfine nail lacquer for non-dermatophyte onychomycosis.
    Bowornsathitchai N; Thammahong A; Shoosanglertwijit J; Kitsongsermthon J; Wititsuwannakul J; Asawanonda P; Boontaveeyuwat E
    Photodermatol Photoimmunol Photomed; 2021 May; 37(3):183-191. PubMed ID: 33145834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylene blue vs methyl aminolevulinate photodynamic therapy in the treatment of mild-to-moderate toenail onychomycosis: Short- and medium-term effects.
    Alberdi E; Gómez C
    Dermatol Ther; 2020 Nov; 33(6):e14280. PubMed ID: 32890444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M; Bulai-Livideanu C; Baran R; Ortonne JP; Richert B; Tosti A; Piraccini BM; Szepietowski JC; Sibaud V; Coubetergues H; Voisard JJ; Paul C
    Dermatology; 2013; 226(1):5-12. PubMed ID: 23467055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral antifungal medication for toenail onychomycosis.
    Kreijkamp-Kaspers S; Hawke K; Guo L; Kerin G; Bell-Syer SE; Magin P; Bell-Syer SV; van Driel ML
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD010031. PubMed ID: 28707751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distal and lateral toenail onychomycosis caused by Trichophyton rubrum: treatment with photodynamic therapy based on methylene blue dye.
    Souza LW; Souza SV; Botelho AC
    An Bras Dermatol; 2014; 89(1):184-6. PubMed ID: 24626676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of toenail thinning and photodynamic therapy in distal and lateral subungual onychomycosis treatment: A case report.
    Guo J; Ding A; Zhang J
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101692. PubMed ID: 32109622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical and device-based treatments for fungal infections of the toenails.
    Foley K; Gupta AK; Versteeg S; Mays R; Villanueva E; John D
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012093. PubMed ID: 31978269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trial comparing photodynamic therapy based on methylene blue dye and fluconazole for toenail onychomycosis.
    Figueiredo Souza LW; Souza SV; Botelho AC
    Dermatol Ther; 2014; 27(1):43-7. PubMed ID: 24502311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial.
    Zalacain-Vicuña AJ; Nieto C; Picas J; Martínez H; Bermejo R; Corrales A; Campos FF; Igea SA; Otero-Espinar FJ; Briones VG
    Mycoses; 2023 Jul; 66(7):566-575. PubMed ID: 36336989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endonyx toenail onychomycosis caused by Trichophyton rubrum: treatment with photodynamic therapy based on methylene blue dye.
    Souza LW; Souza SV; Botelho AC
    An Bras Dermatol; 2013; 88(6):1019-21. PubMed ID: 24474123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.
    Syed TA; Ahmadpour OA; Ahmad SA; Shamsi S
    J Dermatol; 1998 Oct; 25(10):648-52. PubMed ID: 9830263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse versus continuous terbinafine for onychomycosis: a randomized, double-blind, controlled trial.
    Warshaw EM; Fett DD; Bloomfield HE; Grill JP; Nelson DB; Quintero V; Carver SM; Zielke GR; Lederle FA
    J Am Acad Dermatol; 2005 Oct; 53(4):578-84. PubMed ID: 16198776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fifth toenail clinical response to systemic antifungal therapy is not a marker of successful therapy for other toenails with onychomycosis.
    Avner S; Nir N; Henri T
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1194-6. PubMed ID: 17062030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse itraconazole vs. continuous terbinafine for the treatment of dermatophyte toenail onychomycosis in patients with diabetes mellitus.
    Gupta AK; Gover MD; Lynde CW
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1188-93. PubMed ID: 17062029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of methylene blue-mediated photodynamic therapy vs intense pulsed light in the treatment of onychomycosis in the toenails.
    Alberdi E; Gómez C
    Photodermatol Photoimmunol Photomed; 2019 Mar; 35(2):69-77. PubMed ID: 30168611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of onychomycosis: a randomized, double-blind comparison study with topical bifonazole-urea ointment alone and in combination with short-duration oral griseofulvin.
    Friedman-Birnbaum R; Cohen A; Shemer A; Bitterman O; Bergman R; Stettendorf S
    Int J Dermatol; 1997 Jan; 36(1):67-9. PubMed ID: 9071624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
    Gupta AK; Surprenant MS; Kempers SE; Pariser DM; Rensfeldt K; Tavakkol A
    J Am Acad Dermatol; 2021 Jul; 85(1):95-104. PubMed ID: 32585278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.